Frequency and clinico-pathological associations of RAS mutations in colorectal cancer in the Victorian population

Australian and New Zealand Journal of Surgery

Volumn 67, Issue 5, 1997, Pages 233-238

  Thomas, Robert J S ^a,b   Liu, Yong Shu ^a   St Clair, Fiona ^a   Norris, Pamela M ^a   Valentine, Renata ^b   Phillips, Wayne A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WESTERN HOSPITAL   (Australia)

Author keywords

Colorectal cancer; PCR; Ras; Screening

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; AUSTRALIA; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE RAS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE;

EID: 0030737967     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1997.tb01954.x     Document Type: Article

References (32)

1. Rosenthal MA, Ramsay RG. Molecular biology of colorectal oncogenesis. Diagn. Oncol. 1994; 4: 73-9.
2. Cunningham C, Dunlop MG. Molecular genetic basis of colorectal cancer susceptibility. Br. J. Surg. 1996; 83: 321-9.
3. Sidransky D, Tokino T, Hamilton SR et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumours. Science 1992; 256: 102-5.
4. Hasegawa Y, Takeda S, Ichii S et al. Detection of K-ras mutations in DNAs isolated from faeces of patients with colorectal tumours by mutant-allele-specific amplification (MASA). Oncogene 1995; 10: 1441-5.
5. Smithravin J, England J, Talbot IC, Bodmer W. Detection of c-ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut 1995; 36: 81-6.
6. Tobi M, Luo FC, Ronai Z. Detection of K-ras mutation in colonic effluent samples from patients without evidence of colorectal carcinoma. J. Natl. Cancer Inst. 1994; 86: 1007-10.
7. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: A conserved switch for diverse cell functions. Nature 1990; 348: 125-32.
8. Abrams SI, Hand PH, Tsang KY, Schlom J. Mutant ras epitopes as targets for cancer vaccines. Semin. Oncol. 1996; 23: 118-34.
9. Prendergast GC, Gibbs JB. Ras regulatory interactions: Novel targets for anti-cancer intervention. Bioessays 1994; 16: 187-91.
10. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
11. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumour development. N. Engl. J. Med. 1988; 319: 525-32.
12. Pretlow TP, Brasitus TA, Fulton NC, Cheyer C, Kaplan EL. K-ras mutation in putative preneoplastic lesions in human colon. J. Natl. Cancer Inst. 1993; 85: 2004-7.
13. Smith AJ, Stern HS, Penner M et al. Somatic APC and k-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res. 1994; 54: 5527-30.
14. Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H. Frequent and characteristic k-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology 1995; 108: 434-40.
15. Berthelemy P, Bouisson M, Escourrou J, Vaysse N, Rumeau JL, Pradayrol L. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann. Intern. Med. 1995; 123: 188-91.
16. Liu Y, Thomas RJS, Phillips WA. Single-step direct PCR amplification from solid tissues. Nucleic Acids Res. 1995; 23: 1640.
17. Qian L, Wilkinson M. DNA fragment purification: Removal of agarose 10 min after electrophoresis. Biotechniques 1991; 10: 736-8.
18. Draper N, Smith H. Applied Regression Analysis. New York: Wiley, 1981.
19. Hocking R. Analysis and selection of variables in linear regression. Biometrics 1976; 32: 1-49.
20. Breivik J, Meling GI, Spurkland A, Rognum TO, Gaudernack G. K-ras mutation in colorectal cancer: Relations to patient age, sex and tumour location. Br. J. Cancer 1994; 69: 367-71.
21. Bos JL, Fearon ER, Hamilton SR et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293-7.
22. Morrin M, Kelly M, Barren N. Delaney P. Mutations of ki-ras and p53 genes in colorectal cancer and their prognostic significance. Gut 1994; 35: 1627-31.
23. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987; 327: 298-303.
24. Lampe JW, Fredstrom SB, Slavin JL, Potter JD. Sex differences in colonic function: A randomized trial. Cut 1993; 34: 531-6.
25. McMichael AJ, Potter JD. Host factors in carcinogenesis: Certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer. J. Natl. Cancer Inst. 1985; 75: 185-91.
26. Westra WH, Slebos RJ, Offerhaus GJ et al. K-ras oncogene activation in lung adenocarcinoma from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung. Cancer 1993; 72: 432-8.
27. Vainio H, Husgafvel-Persiainen K, Anttila S, Karjalainen A, Hackman P, Partanen T. Interaction between smoking and asbestos in human lung adenocarcinoma: Role of K-ras mutations. Environ. Health Perspect. 1993; 101: 189-92.
28. Finkelstein SD, Sayegh R, Christensen S, Swalsky PA. Genotypic classification of colorectal adenocarcinoma. Biologic behaviour correlates with K-ras-2 mutation type. Cancer 1993; 71: 3827-38.
29. Moerkerk P, Arends JW, van Driel M, de Bruine A, de Goeij A, ten Kate J. Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res. 1994; 54: 3376-8.
30. Losi L, Benhattar J, Costa J. Stability of K-ras mutations throughout the natural history of human colorectal cancer. Eur. J. Cancer 1992; 28A: 1115-20.
31. Chung DC, Rustgi AK. DNA mismatch repair and cancer. Gastroenterology 1995; 109: 1685-99.
32. Kolodner RD. Mismatch repair: Mechanisms and relationship to cancer susceptibility. Trends Biochem. Sci. 1995; 20: 397-401.